These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 24944084)
1. The NMDAr antagonist ketamine interferes with manipulation of information for transitive inference reasoning in non-human primates. Brunamonti E; Mione V; Di Bello F; De Luna P; Genovesio A; Ferraina S J Psychopharmacol; 2014 Sep; 28(9):881-7. PubMed ID: 24944084 [TBL] [Abstract][Full Text] [Related]
2. Effects of the NMDA antagonist ketamine on task-switching performance: evidence for specific impairments of executive control. Stoet G; Snyder LH Neuropsychopharmacology; 2006 Aug; 31(8):1675-81. PubMed ID: 16205773 [TBL] [Abstract][Full Text] [Related]
4. N-methyl-d-aspartate receptor antagonist ketamine impairs action-monitoring activity in the prefrontal cortex. Skoblenick K; Everling S J Cogn Neurosci; 2014 Mar; 26(3):577-92. PubMed ID: 24188365 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis). Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485 [TBL] [Abstract][Full Text] [Related]
6. NMDA antagonist ketamine reduces task selectivity in macaque dorsolateral prefrontal neurons and impairs performance of randomly interleaved prosaccades and antisaccades. Skoblenick K; Everling S J Neurosci; 2012 Aug; 32(35):12018-27. PubMed ID: 22933786 [TBL] [Abstract][Full Text] [Related]
7. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Malhotra AK; Pinals DA; Weingartner H; Sirocco K; Missar CD; Pickar D; Breier A Neuropsychopharmacology; 1996 May; 14(5):301-7. PubMed ID: 8703299 [TBL] [Abstract][Full Text] [Related]
10. Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains. Weed MR; Bookbinder M; Polino J; Keavy D; Cardinal RN; Simmermacher-Mayer J; Cometa FN; King D; Thangathirupathy S; Macor JE; Bristow LJ Neuropsychopharmacology; 2016 Jan; 41(2):568-77. PubMed ID: 26105137 [TBL] [Abstract][Full Text] [Related]
11. Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys. Sun L; Li Q; Li Q; Zhang Y; Liu D; Jiang H; Pan F; Yew DT Addict Biol; 2014 Mar; 19(2):185-94. PubMed ID: 23145560 [TBL] [Abstract][Full Text] [Related]
12. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Malhotra AK; Pinals DA; Adler CM; Elman I; Clifton A; Pickar D; Breier A Neuropsychopharmacology; 1997 Sep; 17(3):141-50. PubMed ID: 9272481 [TBL] [Abstract][Full Text] [Related]
13. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys. Adams BW; Bradberry CW; Moghaddam B Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729 [TBL] [Abstract][Full Text] [Related]
14. NMDA receptor antagonists and pain: ketamine. Muir WW Vet Clin North Am Equine Pract; 2010 Dec; 26(3):565-78. PubMed ID: 21056300 [TBL] [Abstract][Full Text] [Related]
15. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Parwani A; Weiler MA; Blaxton TA; Warfel D; Hardin M; Frey K; Lahti AC Psychopharmacology (Berl); 2005 Dec; 183(3):265-74. PubMed ID: 16220331 [TBL] [Abstract][Full Text] [Related]
16. The vasodilatory effect of ketamine is independent of the N-methyl-D-aspartate receptor: lack of functional N-methyl-D-aspartate receptors in rat mesenteric artery smooth muscle. Noh HJ; Bae YM; Park SH; Kim JG; Kim B; Kim YS; Kim SH; Cho SI; Woo NS Eur J Anaesthesiol; 2009 Aug; 26(8):676-82. PubMed ID: 19352184 [TBL] [Abstract][Full Text] [Related]
17. Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys. Taffe MA; Weed MR; Gutierrez T; Davis SA; Gold LH Psychopharmacology (Berl); 2002 Mar; 160(3):253-62. PubMed ID: 11889494 [TBL] [Abstract][Full Text] [Related]